Italfarmaco Shares Its Latest Newsletter

January 9, 2020

Italfarmaco shares its latest newsletter, updating on enrollment for its EPIDYS Phase 3 Trial and their schedule of events for 2020. Read the full newsletter here.

Experience the magic this summer!

How is the rare disease community accomplishing goals?

Tune in on February 29 to hear from our panel and moderators on how they are accomplishing goals and living life to the fullest!

Your gift helps Jett Foundation provide programming and opportunities, such as Camp Promise, to many families impacted by Duchenne muscular dystrophy each year.

Accessible Vehicle Fund Applications Open